Influence - Jeffrey Lu, the CEO of Engine Biosciences

Published Date: 24-01-2022

Meet Jeffrey Lu, the CEO of Engine Biosciences who shares how Crispr technology and a network approach to drug discovery is accelerating the discovery of solutions to disease. Michelle Martin finds out more about the venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine and its progress in the field of liver cancer.  This interview is part of a special series featuring speakers  in collaboration with the Peak Magazine's Next Gen Leader Series

Bring Awedio With You Anywhere, Anytime!

Scan QR Code to download the Awedio app and listen to this podcast